Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment
NCT06383325 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2024-04-25
Summary
Detection of hepatotoxcicity in acute leukemia and study the outcome of acute leukemia patients that suffer from hepatic toxiciyt
Conditions
- Liver Toxicity, Chemically-Induced
Interventions
- COMBINATION_PRODUCT
-
Chemotherapy
Detection of hepatotoxicity in acute leukemia patients during chemotherapy
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-01
- Primary Completion
- 2025-05-01
- Completion
- 2025-08-01
More Related Trials
-
Characteristics and Predictors of Liver Injury in Cyclin-dependent Kinase Inhibitors 4/6 (CDK4/6)-Treated Patients With Advanced Breast Cancer
NCT06367335 ·Status: COMPLETED
-
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
NCT04042298 ·Status: COMPLETED
-
Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination
NCT01432301 ·Status: APPROVED_FOR_MARKETING
-
Cancer Related Fatigue in Patients Receiving Chemotherapy
NCT00261534 ·Status: UNKNOWN
-
Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy
NCT04327583 ·Status: UNKNOWN ·Phase: NA
-
Tolerance of Anti-Cancer Therapy in the Elderly
NCT05251922 ·Status: UNKNOWN
-
Optimization of the Targeted Anticancer Therapies
NCT04484064 ·Status: RECRUITING ·Phase: NA
-
Mechanisms and Predictors of Unusual Radiation or Chemotherapy Toxicity
NCT02469194 ·Status: WITHDRAWN
-
Study to Evaluate the Usability of PointCheck
NCT04448314 ·Status: COMPLETED
-
Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot
NCT01007695 ·Status: TERMINATED ·Phase: PHASE1
-
Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity
NCT03685175 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
NCT00002901 ·Status: COMPLETED ·Phase: PHASE1
-
Alpha-Lipoic Acid in Breast Cancer Patients
NCT03908528 ·Status: COMPLETED ·Phase: NA
-
Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
NCT00382733 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
NCT03975205 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Coproporphyrine Isomers and Methotrexate Elimination
NCT00822432 ·Status: COMPLETED
-
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
NCT00892502 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
NCT06297369 ·Status: RECRUITING ·Phase: PHASE2
-
Immunological Responses of COVID-19 Vaccination
NCT05238467 ·Status: COMPLETED
-
Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment
NCT05101265 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Melatonin Supplementation on Fatigue Symptoms During Chemotherapy Treatment of Breast Cancer Patients
NCT06125353 ·Status: COMPLETED ·Phase: NA
-
Impact of Selenium on Methotrexate Induced Spermatotoxicity; A Comparative Study
NCT06951282 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 ·Status: SUSPENDED
-
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
NCT00697437 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
NCT01443481 ·Status: COMPLETED ·Phase: PHASE1